DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported fourth-quarter earnings of $94.2 million.

On a per-share basis, the Dublin-based company said it had net income of $1.42. Earnings, adjusted for non-recurring costs and restructuring costs, were $5.02 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $5.26 per share.

The drugmaker posted revenue of $1.01 billion in the period, which met Street forecasts.

For the year, the company reported profit of $414.8 million, or $6.10 per share. Revenue was reported as $3.83 billion.

Jazz expects full-year earnings in the range of $18.15 to $19.35 per share, with revenue in the range of $4 billion to $4.2 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News